Chodakewitz Jeffrey — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Chodakewitz Jeffrey has filed 3 SEC Form 4 filings across 3 companies in the last 90 days.
Profile
Jeffrey Chodakewitz is listed in SEC filings as a Director of Praxis Precision Medicines, Inc. as of June 12, 2026. The available context provides limited information about his broader career or background beyond his board role. Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing precision medicines for neurological and psychiatric conditions. As a director, Chodakewitz would participate in governance, fiduciary duties, and oversight of corporate strategy and financial reporting. There is no publicly available indication in the provided context that he is deceased.
Role
Director
Notability
55/100
Board memberships
Praxis Precision Medicines, Inc.
Awards & honors
Director at Praxis Precision Medicines, Inc. (as of 2026)
Jeffrey Chodakewitz is listed in SEC filings as a Director of Praxis Precision Medicines, Inc. as of June 12, 2026. The available context provides limited information about his broader career or background beyond his board role. Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing precision medicines for neurological and psychiatric con…
How many SEC Form 4 filings has Chodakewitz Jeffrey submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Where can I see all of Chodakewitz Jeffrey's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
